Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The protein encoded by TRIM14 is a member of the tripartite motif (TRIM) family. Zusätzlich bieten wir Ihnen TRIM14 Antikörper (33) und und viele weitere Produktgruppen zu diesem Protein an.
Showing 3 out of 3 products:
Our findings collectively suggest that TRIM14 functions as an oncogene (zeige RAB1A Proteine) by upregulating the AKT (zeige AKT1 Proteine) signaling pathway in osteosarcoma cells, supporting its potential utility as a therapeutic target for this disease.
Study shows that tripartite Motif 14 (TRIM14) is a putative tumor suppressor and regulator of innate immune response in non-small cell lung cancer. The functional data establishes a novel tumor suppressive role for TRIM14 in non-small cell lung cancer progression.
we identify the tripartite motif-containing protein (TRIM14) as a target of miR (zeige MLXIP Proteine)-195-5p. Therefore, we reason that the tumor suppressor role of miR (zeige MLXIP Proteine)-195-5p in oral squamous cell carcinoma is dependent on the interaction with TRIM14.
In searching for mechanisms how TRIM14 exerts its antiviral function we found that TRIM14 interacted with HCV encoded non-structural protein NS5A and could strongly induce its degradation dependent on the NS5A1 subdomain. Interestingly extensive domain mapping analyses revealed that NS5A degradation was mediated by the highly conserved SPRY domain of TRIM14, which might involve the K48 ubiquitination pathway
findings define the WHIP (zeige WRNIP1 Proteine)-TRIM14-PPP6C (zeige PPP6C Proteine) mitochondrial signalosome required for RIG-I (zeige DDX58 Proteine)-mediated innate antiviral immunity.
study identifies new gene-type zinc finger protein 125 (RNF125 (zeige RNF125 Proteine)) as a negative regulator of TRIM14 in the innate antiviral immune response
survival of xenograft mice was prolonged by BsAbBmi/TRIM (zeige TRAT1 Proteine) treatment compared to either AbBmi-1 or AbTRIM-14 treatment. In conclusion, these results provided new evidence that BsAbBmi/TRIM (zeige TRAT1 Proteine) inhibited the progression of osteosarcoma, which suggest that BsAbBmi/TRIM (zeige TRAT1 Proteine) may be a novel anti-cancer agent for osteosarcoma therapy
MiR (zeige MLXIP Proteine)-15b degrades TRIM14 in oral tongue squamous cell cancer.TRIM14 role in oral tongue squamous cell cancer resistance to cisplatin.
Data suggest that tripartite motif containing 14 protein (TRIM14) might play an important role in the malignant progression of tongue squamous cells carcinoma (TSCC) and in regulation of the NF_Kappa B (NF-kappaB (zeige NFKB1 Proteine)) signaling pathway.
stable enhanced expression of trim14 gene in cells activates the transcription of many immunity genes and suppresses Sindbis virus reproduction, but Sindbis virus infection of HEK (zeige EPHA3 Proteine)-trim14 cells promotes inhibition of some genes involved in innate immunity.
TRIM14 inhibits cGAS degradation mediated by selective autophagy receptor p62 to promote innate immune responses.
These results demonstrate the presence of the similar mechanism of trim14 gene action in different types of mammalian cells.
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies and its function has not been determined. Alternative splicing results in multiple transcript variants.
tripartite motif protein TRIM14
, tripartite motif-containing 14
, tripartite motif-containing protein 14-like
, tripartite motif containing 14
, tripartite motif-containing protein 14
, PU.1 binding protein Pub
, PU.1-binding protein
, tripartite motif protein 14